Analysen zu Novo Nordisk
| 17.10.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.10.25 | Novo Nordisk Outperform | Bernstein Research | |
| 13.10.25 | Novo Nordisk Neutral | UBS AG | |
| 10.10.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 09.10.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.10.25 | Novo Nordisk Neutral | UBS AG | |
| 06.10.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.10.25 | Novo Nordisk Neutral | UBS AG | |
| 01.10.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 30.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 22.09.25 | Novo Nordisk Neutral | UBS AG | |
| 19.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 18.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 18.09.25 | Novo Nordisk Neutral | UBS AG | |
| 18.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.09.25 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.09.25 | Novo Nordisk Neutral | UBS AG | |
| 15.09.25 | Novo Nordisk Neutral | UBS AG | |
| 11.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.09.25 | Novo Nordisk Outperform | Bernstein Research | |
| 10.09.25 | Novo Nordisk Neutral | UBS AG | |
| 10.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.09.25 | Novo Nordisk Neutral | UBS AG | |
| 05.09.25 | Novo Nordisk Neutral | UBS AG | |
| 04.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 01.09.25 | Novo Nordisk Neutral | UBS AG | |
| 29.08.25 | Novo Nordisk Neutral | UBS AG | |
| 27.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 26.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 21.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 19.08.25 | Novo Nordisk Neutral | UBS AG | |
| 18.08.25 | Novo Nordisk Neutral | UBS AG | |
| 12.08.25 | Novo Nordisk Neutral | UBS AG | |
| 11.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 08.08.25 | Novo Nordisk Neutral | UBS AG | |
| 08.08.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 08.08.25 | Novo Nordisk Halten | DZ BANK | |
| 07.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.08.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.08.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 06.08.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.08.25 | Novo Nordisk Neutral | UBS AG | |
| 05.08.25 | Novo Nordisk Neutral | UBS AG | |
| 04.08.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 01.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 30.07.25 | Novo Nordisk Equal Weight | Barclays Capital | |
| 30.07.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 29.07.25 | Novo Nordisk Halten | DZ BANK |
Aktuelle Aktienanalysen
| 06.08.26 | Scout24 Buy | Jefferies & Company Inc. | |
| 06.08.26 | Fresenius Buy | Deutsche Bank AG | |
| 06.08.26 | Münchener Rückversicherungs-Gesellschaft Hold | Jefferies & Company Inc. | |
| 06.08.26 | Infineon Neutral | UBS AG | |
| 06.08.26 | Ahold Delhaize Neutral | UBS AG | |
| 06.08.26 | SUSS MicroTec Buy | UBS AG | |
| 06.08.26 | Swiss Re Sell | UBS AG | |
| 06.08.26 | Delivery Hero Neutral | UBS AG | |
| 06.08.26 | arGEN-X Neutral | UBS AG | |
| 06.08.26 | Fraport Neutral | UBS AG | |
| 06.08.26 | SUSS MicroTec Hold | Warburg Research | |
| 06.08.26 | Deutsche Telekom Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.08.26 | RATIONAL Sector Perform | RBC Capital Markets | |
| 06.08.26 | Commerzbank Neutral | JP Morgan Chase & Co. | |
| 06.08.26 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 06.08.26 | Henkel vz. Underweight | JP Morgan Chase & Co. | |
| 06.08.26 | AMD Neutral | JP Morgan Chase & Co. | |
| 06.08.26 | AUMOVIO Buy | UBS AG | |
| 06.08.26 | DHL Group Hold | Warburg Research | |
| 06.08.26 | SAF-HOLLAND Buy | Warburg Research | |
| 06.08.26 | IONOS Overweight | JP Morgan Chase & Co. | |
| 06.08.26 | AUMOVIO Market-Perform | Bernstein Research | |
| 06.08.26 | DEUTZ Buy | Warburg Research | |
| 06.08.26 | Infineon Outperform | Bernstein Research | |
| 06.08.26 | Aurubis Buy | Warburg Research | |
| 06.08.26 | Fraport Buy | Jefferies & Company Inc. | |
| 06.08.26 | ProSiebenSat.1 Media Market-Perform | Bernstein Research | |
| 06.08.26 | Siemens Energy Buy | Deutsche Bank AG | |
| 06.08.26 | Infineon Buy | Deutsche Bank AG | |
| 06.08.26 | Verbund Sell | UBS AG | |
| 06.08.26 | Lenzing neutral | Deutsche Bank AG | |
| 06.08.26 | Deutsche Beteiligungs Buy | Jefferies & Company Inc. | |
| 06.08.26 | Siemens Outperform | Bernstein Research | |
| 06.08.26 | Rheinmetall Buy | Jefferies & Company Inc. | |
| 06.08.26 | Fraport Hold | Deutsche Bank AG | |
| 06.08.26 | Novo Nordisk Neutral | Goldman Sachs Group Inc. | |
| 06.08.26 | DHL Group Overweight | Barclays Capital | |
| 06.08.26 | Siemens Hold | Deutsche Bank AG | |
| 06.08.26 | Fresenius Overweight | Barclays Capital | |
| 06.08.26 | Fresenius Medical Care Equal Weight | Barclays Capital | |
| 06.08.26 | Michelin Equal Weight | Barclays Capital | |
| 06.08.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 06.08.26 | PVA TePla Buy | Jefferies & Company Inc. | |
| 06.08.26 | Swiss Re Underperform | RBC Capital Markets | |
| 06.08.26 | Scout24 Buy | UBS AG | |
| 06.08.26 | SGL Carbon Hold | Jefferies & Company Inc. | |
| 06.08.26 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
| 06.08.26 | Fraport Overweight | JP Morgan Chase & Co. | |
| 06.08.26 | RENK Overweight | JP Morgan Chase & Co. | |
| 06.08.26 | Basler Buy | Warburg Research |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.